The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction

The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction

Saved in:
Bibliographic Details
Published in:European heart journal Vol. 26; no. 23; pp. 2479 - 2481
Main Authors: Svilaas, Tone, van der Horst, Iwan C.C., Zijlstra, Felix
Format: Journal Article
Language:English
Published: England Oxford University Press 01-12-2005
Oxford Publishing Limited (England)
Subjects:
Angioplasty, Balloon, Coronary
Humans
Myocardial Infarction - etiology
Myocardial Infarction - therapy
Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors
Risk Factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ark:/67375/HXZ-266CQGJD-N
This editorial refers to ‘Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study’† by The Admiral Investigators on page 2520
local:ehi553
istex:912959E8C77EC54699D22973404794AE23F55C2B
Corresponding author. Tel: +31 50 3610444; fax: +31 50 3611347. E-mail address: t.svilaas@thorax.umcg.nl
href:ehi553
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehi553